nodes	percent_of_prediction	percent_of_DWPC	metapath
Lomitapide—P-Glycoprotein Inhibitors—Cyclosporine—psoriasis	0.384	0.521	CiPCiCtD
Lomitapide—Cytochrome P450 3A4 Inhibitors—Cyclosporine—psoriasis	0.353	0.479	CiPCiCtD
Lomitapide—CYP3A4—Calcitriol—psoriasis	0.0183	0.103	CbGbCtD
Lomitapide—CYP3A4—Methoxsalen—psoriasis	0.0142	0.0804	CbGbCtD
Lomitapide—ABCB1—Mycophenolate mofetil—psoriasis	0.0136	0.0771	CbGbCtD
Lomitapide—ABCB1—Betamethasone—psoriasis	0.0117	0.0661	CbGbCtD
Lomitapide—ABCB1—Prednisolone—psoriasis	0.0115	0.0653	CbGbCtD
Lomitapide—ABCB1—Hydrocortisone—psoriasis	0.0109	0.0619	CbGbCtD
Lomitapide—ABCB1—Prednisone—psoriasis	0.0109	0.0616	CbGbCtD
Lomitapide—ABCB1—Cyclosporine—psoriasis	0.0103	0.0584	CbGbCtD
Lomitapide—CYP3A4—Cholecalciferol—psoriasis	0.00942	0.0533	CbGbCtD
Lomitapide—CYP3A4—Mycophenolate mofetil—psoriasis	0.00817	0.0462	CbGbCtD
Lomitapide—CYP3A4—Triamcinolone—psoriasis	0.00817	0.0462	CbGbCtD
Lomitapide—CYP3A4—Betamethasone—psoriasis	0.00701	0.0396	CbGbCtD
Lomitapide—CYP3A4—Prednisolone—psoriasis	0.00691	0.0391	CbGbCtD
Lomitapide—ABCB1—Dexamethasone—psoriasis	0.0068	0.0385	CbGbCtD
Lomitapide—CYP3A4—Hydrocortisone—psoriasis	0.00655	0.0371	CbGbCtD
Lomitapide—CYP3A4—Prednisone—psoriasis	0.00653	0.0369	CbGbCtD
Lomitapide—CYP3A4—Cyclosporine—psoriasis	0.00619	0.035	CbGbCtD
Lomitapide—ABCB1—Methotrexate—psoriasis	0.00547	0.0309	CbGbCtD
Lomitapide—CYP3A4—Dexamethasone—psoriasis	0.00408	0.023	CbGbCtD
Lomitapide—Chest pain—Cyclosporine—psoriasis	7.25e-05	0.000847	CcSEcCtD
Lomitapide—Myalgia—Cyclosporine—psoriasis	7.25e-05	0.000847	CcSEcCtD
Lomitapide—Liver function test abnormal—Methotrexate—psoriasis	7.21e-05	0.000843	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—psoriasis	7.2e-05	0.000841	CcSEcCtD
Lomitapide—Ill-defined disorder—Prednisolone—psoriasis	7.19e-05	0.00084	CcSEcCtD
Lomitapide—Discomfort—Cyclosporine—psoriasis	7.16e-05	0.000837	CcSEcCtD
Lomitapide—Dry mouth—Cyclosporine—psoriasis	7.09e-05	0.000828	CcSEcCtD
Lomitapide—Feeling abnormal—Mycophenolic acid—psoriasis	7.08e-05	0.000827	CcSEcCtD
Lomitapide—Chest pain—Mycophenolate mofetil—psoriasis	7.07e-05	0.000826	CcSEcCtD
Lomitapide—Myalgia—Mycophenolate mofetil—psoriasis	7.07e-05	0.000826	CcSEcCtD
Lomitapide—Arthralgia—Mycophenolate mofetil—psoriasis	7.07e-05	0.000826	CcSEcCtD
Lomitapide—Gastrointestinal pain—Mycophenolic acid—psoriasis	7.02e-05	0.00082	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—psoriasis	7.02e-05	0.00082	CcSEcCtD
Lomitapide—Ill-defined disorder—Hydrocortisone—psoriasis	7.02e-05	0.00082	CcSEcCtD
Lomitapide—Diarrhoea—Hydroxyurea—psoriasis	7.01e-05	0.00082	CcSEcCtD
Lomitapide—Malaise—Prednisolone—psoriasis	6.98e-05	0.000816	CcSEcCtD
Lomitapide—Discomfort—Mycophenolate mofetil—psoriasis	6.98e-05	0.000816	CcSEcCtD
Lomitapide—Vertigo—Prednisolone—psoriasis	6.96e-05	0.000813	CcSEcCtD
Lomitapide—Eye disorder—Betamethasone—psoriasis	6.94e-05	0.000811	CcSEcCtD
Lomitapide—Eye disorder—Dexamethasone—psoriasis	6.94e-05	0.000811	CcSEcCtD
Lomitapide—Dry mouth—Mycophenolate mofetil—psoriasis	6.91e-05	0.000808	CcSEcCtD
Lomitapide—Infection—Cyclosporine—psoriasis	6.9e-05	0.000806	CcSEcCtD
Lomitapide—Back pain—Triamcinolone—psoriasis	6.89e-05	0.000805	CcSEcCtD
Lomitapide—Malaise—Hydrocortisone—psoriasis	6.82e-05	0.000797	CcSEcCtD
Lomitapide—Nervous system disorder—Cyclosporine—psoriasis	6.81e-05	0.000796	CcSEcCtD
Lomitapide—Vertigo—Hydrocortisone—psoriasis	6.8e-05	0.000794	CcSEcCtD
Lomitapide—Abdominal pain—Mycophenolic acid—psoriasis	6.79e-05	0.000793	CcSEcCtD
Lomitapide—Body temperature increased—Mycophenolic acid—psoriasis	6.79e-05	0.000793	CcSEcCtD
Lomitapide—Dizziness—Hydroxyurea—psoriasis	6.78e-05	0.000792	CcSEcCtD
Lomitapide—Skin disorder—Cyclosporine—psoriasis	6.75e-05	0.000788	CcSEcCtD
Lomitapide—Infection—Mycophenolate mofetil—psoriasis	6.73e-05	0.000787	CcSEcCtD
Lomitapide—Hyperhidrosis—Cyclosporine—psoriasis	6.72e-05	0.000785	CcSEcCtD
Lomitapide—Nervous system disorder—Mycophenolate mofetil—psoriasis	6.65e-05	0.000777	CcSEcCtD
Lomitapide—Ill-defined disorder—Triamcinolone—psoriasis	6.61e-05	0.000772	CcSEcCtD
Lomitapide—Skin disorder—Mycophenolate mofetil—psoriasis	6.58e-05	0.000769	CcSEcCtD
Lomitapide—Hyperhidrosis—Mycophenolate mofetil—psoriasis	6.55e-05	0.000765	CcSEcCtD
Lomitapide—Vomiting—Hydroxyurea—psoriasis	6.52e-05	0.000762	CcSEcCtD
Lomitapide—Discomfort—Prednisolone—psoriasis	6.52e-05	0.000761	CcSEcCtD
Lomitapide—Abdominal discomfort—Methotrexate—psoriasis	6.47e-05	0.000756	CcSEcCtD
Lomitapide—MTTP—Chylomicron-mediated lipid transport—APOE—psoriasis	6.47e-05	0.158	CbGpPWpGaD
Lomitapide—Myalgia—Hydrocortisone—psoriasis	6.44e-05	0.000753	CcSEcCtD
Lomitapide—Malaise—Triamcinolone—psoriasis	6.42e-05	0.000751	CcSEcCtD
Lomitapide—Headache—Hydroxyurea—psoriasis	6.42e-05	0.00075	CcSEcCtD
Lomitapide—Vertigo—Triamcinolone—psoriasis	6.4e-05	0.000748	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—psoriasis	6.4e-05	0.000747	CcSEcCtD
Lomitapide—Discomfort—Hydrocortisone—psoriasis	6.36e-05	0.000743	CcSEcCtD
Lomitapide—Connective tissue disorder—Prednisone—psoriasis	6.35e-05	0.000742	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Cyclosporine—psoriasis	6.33e-05	0.00074	CcSEcCtD
Lomitapide—Paraesthesia—Cyclosporine—psoriasis	6.24e-05	0.000729	CcSEcCtD
Lomitapide—Somnolence—Cyclosporine—psoriasis	6.18e-05	0.000722	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Mycophenolate mofetil—psoriasis	6.17e-05	0.000721	CcSEcCtD
Lomitapide—Asthenia—Mycophenolic acid—psoriasis	6.16e-05	0.00072	CcSEcCtD
Lomitapide—Infection—Hydrocortisone—psoriasis	6.13e-05	0.000717	CcSEcCtD
Lomitapide—Dyspepsia—Cyclosporine—psoriasis	6.11e-05	0.000715	CcSEcCtD
Lomitapide—Hyperhidrosis—Prednisolone—psoriasis	6.11e-05	0.000714	CcSEcCtD
Lomitapide—Nausea—Hydroxyurea—psoriasis	6.09e-05	0.000712	CcSEcCtD
Lomitapide—Paraesthesia—Mycophenolate mofetil—psoriasis	6.08e-05	0.000711	CcSEcCtD
Lomitapide—Myalgia—Triamcinolone—psoriasis	6.06e-05	0.000709	CcSEcCtD
Lomitapide—Nervous system disorder—Hydrocortisone—psoriasis	6.05e-05	0.000707	CcSEcCtD
Lomitapide—Eye disorder—Prednisone—psoriasis	6.04e-05	0.000706	CcSEcCtD
Lomitapide—Decreased appetite—Cyclosporine—psoriasis	6.04e-05	0.000706	CcSEcCtD
Lomitapide—Somnolence—Mycophenolate mofetil—psoriasis	6.02e-05	0.000704	CcSEcCtD
Lomitapide—Infestation—Methotrexate—psoriasis	6.02e-05	0.000703	CcSEcCtD
Lomitapide—Infestation NOS—Methotrexate—psoriasis	6.02e-05	0.000703	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Cyclosporine—psoriasis	6e-05	0.000701	CcSEcCtD
Lomitapide—Skin disorder—Hydrocortisone—psoriasis	6e-05	0.000701	CcSEcCtD
Lomitapide—Ill-defined disorder—Betamethasone—psoriasis	6e-05	0.000701	CcSEcCtD
Lomitapide—Ill-defined disorder—Dexamethasone—psoriasis	6e-05	0.000701	CcSEcCtD
Lomitapide—Discomfort—Triamcinolone—psoriasis	5.99e-05	0.0007	CcSEcCtD
Lomitapide—Fatigue—Cyclosporine—psoriasis	5.99e-05	0.0007	CcSEcCtD
Lomitapide—Hyperhidrosis—Hydrocortisone—psoriasis	5.97e-05	0.000697	CcSEcCtD
Lomitapide—Dyspepsia—Mycophenolate mofetil—psoriasis	5.97e-05	0.000697	CcSEcCtD
Lomitapide—Constipation—Cyclosporine—psoriasis	5.94e-05	0.000694	CcSEcCtD
Lomitapide—Dry mouth—Triamcinolone—psoriasis	5.93e-05	0.000693	CcSEcCtD
Lomitapide—Decreased appetite—Mycophenolate mofetil—psoriasis	5.89e-05	0.000688	CcSEcCtD
Lomitapide—Diarrhoea—Mycophenolic acid—psoriasis	5.88e-05	0.000686	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	5.85e-05	0.000684	CcSEcCtD
Lomitapide—Malaise—Dexamethasone—psoriasis	5.83e-05	0.000681	CcSEcCtD
Lomitapide—Malaise—Betamethasone—psoriasis	5.83e-05	0.000681	CcSEcCtD
Lomitapide—Vertigo—Dexamethasone—psoriasis	5.81e-05	0.000678	CcSEcCtD
Lomitapide—Vertigo—Betamethasone—psoriasis	5.81e-05	0.000678	CcSEcCtD
Lomitapide—Constipation—Mycophenolate mofetil—psoriasis	5.79e-05	0.000677	CcSEcCtD
Lomitapide—Infection—Triamcinolone—psoriasis	5.78e-05	0.000675	CcSEcCtD
Lomitapide—Haematuria—Methotrexate—psoriasis	5.74e-05	0.000671	CcSEcCtD
Lomitapide—Feeling abnormal—Cyclosporine—psoriasis	5.72e-05	0.000669	CcSEcCtD
Lomitapide—Hepatobiliary disease—Methotrexate—psoriasis	5.69e-05	0.000665	CcSEcCtD
Lomitapide—Gastrointestinal pain—Cyclosporine—psoriasis	5.68e-05	0.000664	CcSEcCtD
Lomitapide—Dizziness—Mycophenolic acid—psoriasis	5.68e-05	0.000663	CcSEcCtD
Lomitapide—Paraesthesia—Prednisolone—psoriasis	5.68e-05	0.000663	CcSEcCtD
Lomitapide—Malnutrition—Prednisone—psoriasis	5.63e-05	0.000658	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Hydrocortisone—psoriasis	5.62e-05	0.000657	CcSEcCtD
Lomitapide—Hyperhidrosis—Triamcinolone—psoriasis	5.62e-05	0.000657	CcSEcCtD
Lomitapide—Feeling abnormal—Mycophenolate mofetil—psoriasis	5.58e-05	0.000653	CcSEcCtD
Lomitapide—Paraesthesia—Hydrocortisone—psoriasis	5.54e-05	0.000648	CcSEcCtD
Lomitapide—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	5.54e-05	0.000647	CcSEcCtD
Lomitapide—Myalgia—Dexamethasone—psoriasis	5.5e-05	0.000643	CcSEcCtD
Lomitapide—Myalgia—Betamethasone—psoriasis	5.5e-05	0.000643	CcSEcCtD
Lomitapide—Abdominal pain—Cyclosporine—psoriasis	5.49e-05	0.000642	CcSEcCtD
Lomitapide—Body temperature increased—Cyclosporine—psoriasis	5.49e-05	0.000642	CcSEcCtD
Lomitapide—Vomiting—Mycophenolic acid—psoriasis	5.46e-05	0.000638	CcSEcCtD
Lomitapide—Discomfort—Dexamethasone—psoriasis	5.44e-05	0.000635	CcSEcCtD
Lomitapide—Discomfort—Betamethasone—psoriasis	5.44e-05	0.000635	CcSEcCtD
Lomitapide—Dyspepsia—Hydrocortisone—psoriasis	5.43e-05	0.000635	CcSEcCtD
Lomitapide—Headache—Mycophenolic acid—psoriasis	5.38e-05	0.000629	CcSEcCtD
Lomitapide—Decreased appetite—Hydrocortisone—psoriasis	5.37e-05	0.000627	CcSEcCtD
Lomitapide—Body temperature increased—Mycophenolate mofetil—psoriasis	5.36e-05	0.000626	CcSEcCtD
Lomitapide—Abdominal pain—Mycophenolate mofetil—psoriasis	5.36e-05	0.000626	CcSEcCtD
Lomitapide—Urinary tract disorder—Methotrexate—psoriasis	5.34e-05	0.000624	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Hydrocortisone—psoriasis	5.33e-05	0.000623	CcSEcCtD
Lomitapide—Fatigue—Hydrocortisone—psoriasis	5.32e-05	0.000622	CcSEcCtD
Lomitapide—Urethral disorder—Methotrexate—psoriasis	5.3e-05	0.000619	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Triamcinolone—psoriasis	5.3e-05	0.000619	CcSEcCtD
Lomitapide—Infection—Betamethasone—psoriasis	5.24e-05	0.000612	CcSEcCtD
Lomitapide—Infection—Dexamethasone—psoriasis	5.24e-05	0.000612	CcSEcCtD
Lomitapide—Ill-defined disorder—Prednisone—psoriasis	5.22e-05	0.00061	CcSEcCtD
Lomitapide—Paraesthesia—Triamcinolone—psoriasis	5.22e-05	0.00061	CcSEcCtD
Lomitapide—Feeling abnormal—Prednisolone—psoriasis	5.21e-05	0.000609	CcSEcCtD
Lomitapide—Anaemia—Prednisone—psoriasis	5.2e-05	0.000608	CcSEcCtD
Lomitapide—Nervous system disorder—Dexamethasone—psoriasis	5.17e-05	0.000604	CcSEcCtD
Lomitapide—Nervous system disorder—Betamethasone—psoriasis	5.17e-05	0.000604	CcSEcCtD
Lomitapide—Dyspepsia—Triamcinolone—psoriasis	5.12e-05	0.000598	CcSEcCtD
Lomitapide—Nausea—Mycophenolic acid—psoriasis	5.1e-05	0.000596	CcSEcCtD
Lomitapide—Hyperhidrosis—Dexamethasone—psoriasis	5.1e-05	0.000596	CcSEcCtD
Lomitapide—Hyperhidrosis—Betamethasone—psoriasis	5.1e-05	0.000596	CcSEcCtD
Lomitapide—Feeling abnormal—Hydrocortisone—psoriasis	5.09e-05	0.000594	CcSEcCtD
Lomitapide—Malaise—Prednisone—psoriasis	5.08e-05	0.000593	CcSEcCtD
Lomitapide—Vertigo—Prednisone—psoriasis	5.06e-05	0.000591	CcSEcCtD
Lomitapide—Eye disorder—Methotrexate—psoriasis	5.05e-05	0.00059	CcSEcCtD
Lomitapide—Gastrointestinal pain—Hydrocortisone—psoriasis	5.05e-05	0.00059	CcSEcCtD
Lomitapide—Cardiac disorder—Methotrexate—psoriasis	5.01e-05	0.000586	CcSEcCtD
Lomitapide—Fatigue—Triamcinolone—psoriasis	5.01e-05	0.000586	CcSEcCtD
Lomitapide—Asthenia—Cyclosporine—psoriasis	4.98e-05	0.000582	CcSEcCtD
Lomitapide—Abdominal pain—Hydrocortisone—psoriasis	4.88e-05	0.00057	CcSEcCtD
Lomitapide—Body temperature increased—Hydrocortisone—psoriasis	4.88e-05	0.00057	CcSEcCtD
Lomitapide—Mediastinal disorder—Methotrexate—psoriasis	4.87e-05	0.000569	CcSEcCtD
Lomitapide—Asthenia—Mycophenolate mofetil—psoriasis	4.86e-05	0.000568	CcSEcCtD
Lomitapide—Chills—Methotrexate—psoriasis	4.85e-05	0.000567	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Dexamethasone—psoriasis	4.81e-05	0.000562	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Betamethasone—psoriasis	4.81e-05	0.000562	CcSEcCtD
Lomitapide—Arthralgia—Prednisone—psoriasis	4.79e-05	0.00056	CcSEcCtD
Lomitapide—Myalgia—Prednisone—psoriasis	4.79e-05	0.00056	CcSEcCtD
Lomitapide—Feeling abnormal—Triamcinolone—psoriasis	4.79e-05	0.00056	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	4.76e-05	0.000556	CcSEcCtD
Lomitapide—Diarrhoea—Cyclosporine—psoriasis	4.75e-05	0.000555	CcSEcCtD
Lomitapide—Paraesthesia—Dexamethasone—psoriasis	4.74e-05	0.000553	CcSEcCtD
Lomitapide—Paraesthesia—Betamethasone—psoriasis	4.74e-05	0.000553	CcSEcCtD
Lomitapide—Discomfort—Prednisone—psoriasis	4.73e-05	0.000553	CcSEcCtD
Lomitapide—Malnutrition—Methotrexate—psoriasis	4.7e-05	0.00055	CcSEcCtD
Lomitapide—Dyspepsia—Dexamethasone—psoriasis	4.64e-05	0.000543	CcSEcCtD
Lomitapide—Dyspepsia—Betamethasone—psoriasis	4.64e-05	0.000543	CcSEcCtD
Lomitapide—Diarrhoea—Mycophenolate mofetil—psoriasis	4.64e-05	0.000542	CcSEcCtD
Lomitapide—Body temperature increased—Triamcinolone—psoriasis	4.6e-05	0.000537	CcSEcCtD
Lomitapide—Dizziness—Cyclosporine—psoriasis	4.59e-05	0.000537	CcSEcCtD
Lomitapide—Decreased appetite—Dexamethasone—psoriasis	4.59e-05	0.000536	CcSEcCtD
Lomitapide—Decreased appetite—Betamethasone—psoriasis	4.59e-05	0.000536	CcSEcCtD
Lomitapide—Infection—Prednisone—psoriasis	4.56e-05	0.000533	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Betamethasone—psoriasis	4.55e-05	0.000532	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Dexamethasone—psoriasis	4.55e-05	0.000532	CcSEcCtD
Lomitapide—Back pain—Methotrexate—psoriasis	4.55e-05	0.000532	CcSEcCtD
Lomitapide—Fatigue—Dexamethasone—psoriasis	4.55e-05	0.000531	CcSEcCtD
Lomitapide—Fatigue—Betamethasone—psoriasis	4.55e-05	0.000531	CcSEcCtD
Lomitapide—Nervous system disorder—Prednisone—psoriasis	4.5e-05	0.000526	CcSEcCtD
Lomitapide—Dizziness—Mycophenolate mofetil—psoriasis	4.48e-05	0.000524	CcSEcCtD
Lomitapide—Skin disorder—Prednisone—psoriasis	4.46e-05	0.000521	CcSEcCtD
Lomitapide—Hyperhidrosis—Prednisone—psoriasis	4.44e-05	0.000519	CcSEcCtD
Lomitapide—Asthenia—Hydrocortisone—psoriasis	4.43e-05	0.000518	CcSEcCtD
Lomitapide—Vomiting—Cyclosporine—psoriasis	4.42e-05	0.000516	CcSEcCtD
Lomitapide—Ill-defined disorder—Methotrexate—psoriasis	4.36e-05	0.00051	CcSEcCtD
Lomitapide—Headache—Cyclosporine—psoriasis	4.35e-05	0.000509	CcSEcCtD
Lomitapide—Anaemia—Methotrexate—psoriasis	4.35e-05	0.000508	CcSEcCtD
Lomitapide—Feeling abnormal—Dexamethasone—psoriasis	4.35e-05	0.000508	CcSEcCtD
Lomitapide—Feeling abnormal—Betamethasone—psoriasis	4.35e-05	0.000508	CcSEcCtD
Lomitapide—Gastrointestinal pain—Dexamethasone—psoriasis	4.31e-05	0.000504	CcSEcCtD
Lomitapide—Gastrointestinal pain—Betamethasone—psoriasis	4.31e-05	0.000504	CcSEcCtD
Lomitapide—Vomiting—Mycophenolate mofetil—psoriasis	4.31e-05	0.000503	CcSEcCtD
Lomitapide—Headache—Mycophenolate mofetil—psoriasis	4.25e-05	0.000496	CcSEcCtD
Lomitapide—Malaise—Methotrexate—psoriasis	4.24e-05	0.000496	CcSEcCtD
Lomitapide—Vertigo—Methotrexate—psoriasis	4.23e-05	0.000494	CcSEcCtD
Lomitapide—Diarrhoea—Hydrocortisone—psoriasis	4.22e-05	0.000494	CcSEcCtD
Lomitapide—MTTP—Statin Pathway—APOE—psoriasis	4.22e-05	0.103	CbGpPWpGaD
Lomitapide—Musculoskeletal discomfort—Prednisone—psoriasis	4.19e-05	0.000489	CcSEcCtD
Lomitapide—Dizziness—Prednisolone—psoriasis	4.18e-05	0.000488	CcSEcCtD
Lomitapide—Asthenia—Triamcinolone—psoriasis	4.17e-05	0.000487	CcSEcCtD
Lomitapide—Abdominal pain—Betamethasone—psoriasis	4.17e-05	0.000487	CcSEcCtD
Lomitapide—Body temperature increased—Dexamethasone—psoriasis	4.17e-05	0.000487	CcSEcCtD
Lomitapide—Body temperature increased—Betamethasone—psoriasis	4.17e-05	0.000487	CcSEcCtD
Lomitapide—Abdominal pain—Dexamethasone—psoriasis	4.17e-05	0.000487	CcSEcCtD
Lomitapide—Nausea—Cyclosporine—psoriasis	4.13e-05	0.000482	CcSEcCtD
Lomitapide—Paraesthesia—Prednisone—psoriasis	4.12e-05	0.000482	CcSEcCtD
Lomitapide—MTTP—Lipoprotein metabolism—APOE—psoriasis	4.11e-05	0.1	CbGpPWpGaD
Lomitapide—Dizziness—Hydrocortisone—psoriasis	4.08e-05	0.000477	CcSEcCtD
Lomitapide—Dyspepsia—Prednisone—psoriasis	4.04e-05	0.000472	CcSEcCtD
Lomitapide—Nausea—Mycophenolate mofetil—psoriasis	4.03e-05	0.00047	CcSEcCtD
Lomitapide—Arthralgia—Methotrexate—psoriasis	4e-05	0.000468	CcSEcCtD
Lomitapide—Chest pain—Methotrexate—psoriasis	4e-05	0.000468	CcSEcCtD
Lomitapide—Myalgia—Methotrexate—psoriasis	4e-05	0.000468	CcSEcCtD
Lomitapide—Decreased appetite—Prednisone—psoriasis	3.99e-05	0.000467	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	3.98e-05	0.000465	CcSEcCtD
Lomitapide—Fatigue—Prednisone—psoriasis	3.96e-05	0.000463	CcSEcCtD
Lomitapide—Headache—Prednisolone—psoriasis	3.96e-05	0.000463	CcSEcCtD
Lomitapide—Discomfort—Methotrexate—psoriasis	3.96e-05	0.000462	CcSEcCtD
Lomitapide—Constipation—Prednisone—psoriasis	3.93e-05	0.000459	CcSEcCtD
Lomitapide—Vomiting—Hydrocortisone—psoriasis	3.93e-05	0.000459	CcSEcCtD
Lomitapide—Headache—Hydrocortisone—psoriasis	3.87e-05	0.000452	CcSEcCtD
Lomitapide—Dizziness—Triamcinolone—psoriasis	3.84e-05	0.000449	CcSEcCtD
Lomitapide—Infection—Methotrexate—psoriasis	3.81e-05	0.000446	CcSEcCtD
Lomitapide—Feeling abnormal—Prednisone—psoriasis	3.79e-05	0.000442	CcSEcCtD
Lomitapide—Asthenia—Betamethasone—psoriasis	3.78e-05	0.000442	CcSEcCtD
Lomitapide—Asthenia—Dexamethasone—psoriasis	3.78e-05	0.000442	CcSEcCtD
Lomitapide—Nervous system disorder—Methotrexate—psoriasis	3.76e-05	0.00044	CcSEcCtD
Lomitapide—Gastrointestinal pain—Prednisone—psoriasis	3.76e-05	0.000439	CcSEcCtD
Lomitapide—Nausea—Prednisolone—psoriasis	3.75e-05	0.000439	CcSEcCtD
Lomitapide—Skin disorder—Methotrexate—psoriasis	3.73e-05	0.000436	CcSEcCtD
Lomitapide—Hyperhidrosis—Methotrexate—psoriasis	3.71e-05	0.000434	CcSEcCtD
Lomitapide—Vomiting—Triamcinolone—psoriasis	3.7e-05	0.000432	CcSEcCtD
Lomitapide—Nausea—Hydrocortisone—psoriasis	3.67e-05	0.000428	CcSEcCtD
Lomitapide—Headache—Triamcinolone—psoriasis	3.64e-05	0.000426	CcSEcCtD
Lomitapide—Abdominal pain—Prednisone—psoriasis	3.63e-05	0.000424	CcSEcCtD
Lomitapide—Body temperature increased—Prednisone—psoriasis	3.63e-05	0.000424	CcSEcCtD
Lomitapide—Diarrhoea—Betamethasone—psoriasis	3.61e-05	0.000422	CcSEcCtD
Lomitapide—Diarrhoea—Dexamethasone—psoriasis	3.61e-05	0.000422	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Methotrexate—psoriasis	3.5e-05	0.000409	CcSEcCtD
Lomitapide—Dizziness—Betamethasone—psoriasis	3.49e-05	0.000408	CcSEcCtD
Lomitapide—Dizziness—Dexamethasone—psoriasis	3.49e-05	0.000408	CcSEcCtD
Lomitapide—Nausea—Triamcinolone—psoriasis	3.45e-05	0.000403	CcSEcCtD
Lomitapide—Paraesthesia—Methotrexate—psoriasis	3.45e-05	0.000403	CcSEcCtD
Lomitapide—Somnolence—Methotrexate—psoriasis	3.41e-05	0.000399	CcSEcCtD
Lomitapide—Dyspepsia—Methotrexate—psoriasis	3.38e-05	0.000395	CcSEcCtD
Lomitapide—Vomiting—Dexamethasone—psoriasis	3.35e-05	0.000392	CcSEcCtD
Lomitapide—Vomiting—Betamethasone—psoriasis	3.35e-05	0.000392	CcSEcCtD
Lomitapide—Decreased appetite—Methotrexate—psoriasis	3.34e-05	0.00039	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Methotrexate—psoriasis	3.31e-05	0.000387	CcSEcCtD
Lomitapide—Fatigue—Methotrexate—psoriasis	3.31e-05	0.000387	CcSEcCtD
Lomitapide—Headache—Betamethasone—psoriasis	3.3e-05	0.000386	CcSEcCtD
Lomitapide—Headache—Dexamethasone—psoriasis	3.3e-05	0.000386	CcSEcCtD
Lomitapide—Asthenia—Prednisone—psoriasis	3.3e-05	0.000385	CcSEcCtD
Lomitapide—Feeling abnormal—Methotrexate—psoriasis	3.16e-05	0.00037	CcSEcCtD
Lomitapide—Diarrhoea—Prednisone—psoriasis	3.14e-05	0.000367	CcSEcCtD
Lomitapide—Gastrointestinal pain—Methotrexate—psoriasis	3.14e-05	0.000367	CcSEcCtD
Lomitapide—Nausea—Dexamethasone—psoriasis	3.13e-05	0.000366	CcSEcCtD
Lomitapide—Nausea—Betamethasone—psoriasis	3.13e-05	0.000366	CcSEcCtD
Lomitapide—Dizziness—Prednisone—psoriasis	3.04e-05	0.000355	CcSEcCtD
Lomitapide—Body temperature increased—Methotrexate—psoriasis	3.03e-05	0.000355	CcSEcCtD
Lomitapide—Abdominal pain—Methotrexate—psoriasis	3.03e-05	0.000355	CcSEcCtD
Lomitapide—Vomiting—Prednisone—psoriasis	2.92e-05	0.000341	CcSEcCtD
Lomitapide—Headache—Prednisone—psoriasis	2.88e-05	0.000336	CcSEcCtD
Lomitapide—Asthenia—Methotrexate—psoriasis	2.75e-05	0.000322	CcSEcCtD
Lomitapide—MTTP—Lipid and lipoprotein metabolism—APOE—psoriasis	2.73e-05	0.0668	CbGpPWpGaD
Lomitapide—Nausea—Prednisone—psoriasis	2.73e-05	0.000319	CcSEcCtD
Lomitapide—Diarrhoea—Methotrexate—psoriasis	2.63e-05	0.000307	CcSEcCtD
Lomitapide—Dizziness—Methotrexate—psoriasis	2.54e-05	0.000297	CcSEcCtD
Lomitapide—Vomiting—Methotrexate—psoriasis	2.44e-05	0.000285	CcSEcCtD
Lomitapide—Headache—Methotrexate—psoriasis	2.4e-05	0.000281	CcSEcCtD
Lomitapide—Nausea—Methotrexate—psoriasis	2.28e-05	0.000266	CcSEcCtD
Lomitapide—ABCB1—Allograft Rejection—IL22—psoriasis	2.14e-05	0.0523	CbGpPWpGaD
Lomitapide—CYP3A4—Xenobiotics—CYP2S1—psoriasis	1.64e-05	0.0401	CbGpPWpGaD
Lomitapide—MTTP—Circadian rythm related genes—LEP—psoriasis	8.97e-06	0.0219	CbGpPWpGaD
Lomitapide—ABCB1—Drug Induction of Bile Acid Pathway—VDR—psoriasis	8.85e-06	0.0216	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—NDUFA5—psoriasis	8.76e-06	0.0214	CbGpPWpGaD
Lomitapide—MTTP—Circadian rythm related genes—NOS2—psoriasis	8.36e-06	0.0204	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—CARM1—psoriasis	8.16e-06	0.02	CbGpPWpGaD
Lomitapide—MTTP—Circadian rythm related genes—PPARG—psoriasis	7.81e-06	0.0191	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—CYP2S1—psoriasis	7.45e-06	0.0182	CbGpPWpGaD
Lomitapide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	6.81e-06	0.0167	CbGpPWpGaD
Lomitapide—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	6.73e-06	0.0165	CbGpPWpGaD
Lomitapide—MTTP—Circadian rythm related genes—JUN—psoriasis	5.54e-06	0.0136	CbGpPWpGaD
Lomitapide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	5.52e-06	0.0135	CbGpPWpGaD
Lomitapide—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	5.45e-06	0.0133	CbGpPWpGaD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—CP—psoriasis	5.25e-06	0.0128	CbGpPWpGaD
Lomitapide—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	5.08e-06	0.0124	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—HLA-C—psoriasis	4.05e-06	0.00991	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—IL13—psoriasis	4.02e-06	0.00985	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—APOE—psoriasis	3.9e-06	0.00954	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—IL17A—psoriasis	3.7e-06	0.00906	CbGpPWpGaD
Lomitapide—MTTP—Circadian rythm related genes—TP53—psoriasis	3.66e-06	0.00895	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—CARM1—psoriasis	3.64e-06	0.00889	CbGpPWpGaD
Lomitapide—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	3.54e-06	0.00866	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—IL12B—psoriasis	3.44e-06	0.00842	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—PPARG—psoriasis	3.4e-06	0.00831	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—HLA-E—psoriasis	3.36e-06	0.00822	CbGpPWpGaD
Lomitapide—MTTP—Circadian rythm related genes—IL6—psoriasis	3.35e-06	0.00819	CbGpPWpGaD
Lomitapide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	3.13e-06	0.00766	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—CYP2S1—psoriasis	2.93e-06	0.00718	CbGpPWpGaD
Lomitapide—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	2.89e-06	0.00708	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	2.78e-06	0.0068	CbGpPWpGaD
Lomitapide—CYP3A4—Tryptophan metabolism—CAT—psoriasis	2.53e-06	0.00619	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—IL10—psoriasis	2.52e-06	0.00616	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—IL4—psoriasis	2.45e-06	0.00599	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—HLA-B—psoriasis	2.39e-06	0.00586	CbGpPWpGaD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—LEP—psoriasis	2.39e-06	0.00585	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—CAT—psoriasis	2.24e-06	0.00547	CbGpPWpGaD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriasis	2.23e-06	0.00545	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—HLA-A—psoriasis	2.22e-06	0.00543	CbGpPWpGaD
Lomitapide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	2.18e-06	0.00534	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—HLA-DRB1—psoriasis	2.03e-06	0.00496	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—APOE—psoriasis	1.74e-06	0.00425	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—PPARG—psoriasis	1.51e-06	0.0037	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—IFNG—psoriasis	1.48e-06	0.00362	CbGpPWpGaD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	1.48e-06	0.00361	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—CXCL8—psoriasis	1.38e-06	0.00337	CbGpPWpGaD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	1.29e-06	0.00316	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	1.13e-06	0.00277	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—VEGFA—psoriasis	1.12e-06	0.00274	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—TNF—psoriasis	9.58e-07	0.00234	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—NDUFA5—psoriasis	9.58e-07	0.00234	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	9.53e-07	0.00233	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	8.9e-07	0.00218	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	8.49e-07	0.00208	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CYP2S1—psoriasis	8.15e-07	0.00199	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	6.32e-07	0.00154	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	6.08e-07	0.00149	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—NDUFA5—psoriasis	5.9e-07	0.00144	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	5.52e-07	0.00135	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CYP2S1—psoriasis	5.02e-07	0.00123	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	4.73e-07	0.00116	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	4.17e-07	0.00102	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CARM1—psoriasis	3.98e-07	0.000973	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CARM1—psoriasis	2.45e-07	0.0006	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CAT—psoriasis	2.45e-07	0.000599	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—APOE—psoriasis	1.9e-07	0.000465	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PPARG—psoriasis	1.66e-07	0.000405	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CAT—psoriasis	1.51e-07	0.000369	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—APOE—psoriasis	1.17e-07	0.000287	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PPARG—psoriasis	1.02e-07	0.00025	CbGpPWpGaD
